Group Llc Column serves as Executive at RAPT Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Group Llc Column has executed 8 insider transactions totaling $15.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 10, 2022 involved purchasing 1,208,750 shares valued at $12.9M.
Group Llc Column currently holds 1,208,750 shares of RAPT Therapeutics, Inc. (RAPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Group Llc Column has been a net buyer of RAPT stock. They have purchased $13.3M and sold $2.4M worth of shares.
Group Llc Column's most recent insider trade was on May 10, 2022, when they purchased 1,208,750 shares at $10.67 per share.
Get notified when new Form 4 filings are submitted
| $10.67 |
| Discretionary |
| Sep 2, 2021 | RAPT | $657.0K | Sale | 18,545 | $35.43 | Discretionary |
| Sep 2, 2021 | RAPT | $657.4K | Sale | 18,556 | $35.43 | Discretionary |
| Sep 1, 2021 | RAPT | $308.7K | Sale | 8,805 | $35.06 | Discretionary |
| Sep 1, 2021 | RAPT | $317.7K | Sale | 8,976 | $35.39 | Discretionary |
| Sep 1, 2021 | RAPT | $241.8K | Sale | 6,904 | $35.02 | Discretionary |
| Sep 1, 2021 | RAPT | $250.5K | Sale | 7,064 | $35.46 | Discretionary |